Clinical Trials Browser

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Papillomavirus Infections

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

Adenocarcinoma, Breast Neoplasms

High Grade Cervical Intraepithelial Neoplasia

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

Herpes Zoster

Uterine Cervical Neoplasms, Papillomavirus Infections

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

Brain Neoplasms, Glioblastoma, Melanoma

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

Papillomavirus Infections

Uterine Cervical Dysplasia

Breast Neoplasms, Breast Neoplasms, Male

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NY-ESO-1-expressing Tumors

Influenza, Human, Neoplasms

Uterine Cervical Neoplasms, Condylomata Acuminata

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Lung Neoplasms

Neoplasms, Rheumatic Diseases, HIV Infections

Clinical Trials

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

ABSIDE

Dendritic Cell Vaccination in Patients With Advanced Melanoma

VolATIL

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

SHIVERING 2

V503-010

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

BCGov-01

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Lung Cancer Vaccine Plus Oral Dietary Supplement

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients